Medication Options for Acute Agitation Without IV Access

First-Line Options

Intramuscular lorazepam can be administered at a dose of 2.5-5 mg subcutaneously every 2-4 hours as needed, with consideration of alternative routes when IV access is established, as recommended by the British Medical Journal guidelines 1
Rectal diazepam can be administered when IM options are not feasible, with the understanding that IM diazepam is not recommended due to erratic absorption, according to PLoS Medicine guidelines 2, 3

Intramuscular haloperidol can be used as a second-line option, with an initial dose of 0.5-1 mg for elderly patients and 1.5-3 mg for severely distressed patients, and may be combined with a benzodiazepine for enhanced effect, as per BMJ guidelines 1

Respiratory monitoring is crucial when administering benzodiazepines, as they carry a risk of respiratory depression, and patients should be monitored for respiratory rate, oxygen saturation, and level of consciousness, as advised by the American Society of Anesthesiologists (ASA) 4
A reversal agent like flumazenil should be available when administering benzodiazepines for potential reversal of respiratory depression, according to ASA guidelines 4
Combining multiple CNS depressants increases the risk of respiratory depression and adverse events, and should be avoided, as warned by ASA guidelines 4
Inadequate monitoring can lead to adverse effects, and patients require close monitoring even with non-IV routes, as emphasized by ASA guidelines 4
Delayed reassessment can lead to excessive sedation, and sufficient time should be allowed between doses to assess medication effect before administering additional doses, as recommended by ASA guidelines 4